Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial
Background: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
[PDF][PDF] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction
MN Kosiborod, PS Jhund - Circulation, 2020 - ppm.umw.edu.pl
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
[引用][C] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF …
MN Kosiborod, PS Jhund, KF Docherty, M Diez… - Circulation, 2020 - repositorio.usp.br
ReP USP - Detalhe do registro: Effects of Dapagliflozin on Symptoms, Function, and Quality
of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF …
of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF …
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
MN Kosiborod, PS Jhund, KF Docherty, M Diez… - Circulation, 2019 - europepmc.org
Background Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: Results from the DAPA-HF Trial
MN Kosiborod, PS Jhund, KF Docherty… - …, 2019 - acuresearchbank.acu.edu.au
Background: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction
MN Kosiborod, PS Jhund - Circulation, 2020 - Am Heart Assoc
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
[PDF][PDF] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction
MN Kosiborod, PS Jhund - Circulation, 2020 - dapatrial.org
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
MN Kosiborod, PS Jhund, KF Docherty, M Diez… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
[PDF][PDF] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction
MN Kosiborod, PS Jhund - Circulation, 2020 - core.ac.uk
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
MN Kosiborod, PS Jhund, KF Docherty, M Diez… - …, 2020 - ingentaconnect.com
Background: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …
fraction include reducing death and hospitalizations, and improving health status …